Chemoinformaics analysis of 1-Pyrrolidineethanamine
Molecular Weight | 114.192 | nRot | 2 |
Heavy Atom Molecular Weight | 100.08 | nRig | 5 |
Exact Molecular Weight | 114.116 | nRing | 1 |
Solubility: LogS | 0.821 | nHRing | 1 |
Solubility: LogP | -0.194 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 21.5551 |
nHD | 1 | BPOL | 15.1849 |
QED | 0.549 |
Synth | 1.867 |
Natural Product Likeliness | -1.139 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.022 |
Pgp-sub | 0.008 |
HIA | 0.029 |
CACO-2 | -5.451 |
MDCK | 0.0000171 |
BBB | 0.504 |
PPB | 0.0912132 |
VDSS | 1.669 |
FU | 0.878448 |
CYP1A2-inh | 0.019 |
CYP1A2-sub | 0.112 |
CYP2c19-inh | 0.021 |
CYP2c19-sub | 0.738 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.097 |
CYP2d6-inh | 0.025 |
CYP2d6-sub | 0.896 |
CYP3a4-inh | 0.001 |
CYP3a4-sub | 0.213 |
CL | 7.87 |
T12 | 0.347 |
hERG | 0.056 |
Ames | 0.05 |
ROA | 0.571 |
SkinSen | 0.914 |
Carcinogencity | 0.298 |
EI | 0.293 |
Respiratory | 0.95 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.954714 |